BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2021.12.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Kassab K, Soni R, Kassier A, Fischell TA. The Potential Role of Renal Denervation in the Management of Heart Failure. J Clin Med 2022;11:4147. [PMID: 35887912 DOI: 10.3390/jcm11144147] [Reference Citation Analysis]
2 Xue F, Cheng J, Liu Y, Cheng C, Zhang M, Sui W, Chen W, Hao P, Zhang Y, Zhang C. Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice. Signal Transduct Target Ther 2022;7:259. [PMID: 35909160 DOI: 10.1038/s41392-022-01054-3] [Reference Citation Analysis]
3 D’elia JA, Bayliss GP, Weinrauch LA. The Diabetic Cardiorenal Nexus. IJMS 2022;23:7351. [DOI: 10.3390/ijms23137351] [Reference Citation Analysis]
4 Tadic M, Cuspidi C. Sacubitril/Valsartan in the Treatment of Resistant Hypertension: Raising Star or Illusion? J Clin Med 2022;11:3081. [PMID: 35683468 DOI: 10.3390/jcm11113081] [Reference Citation Analysis]
5 Sauer AJ. Empagliflozin and Elderly Patients With Preserved Ejection Fraction Heart Failure: Is Age Just a Number? J Am Coll Cardiol 2022;80:19-21. [PMID: 35772912 DOI: 10.1016/j.jacc.2022.04.037] [Reference Citation Analysis]
6 Briasoulis A, Kuno T, Asleh R, Doulamis IP, Malik A. Evolution of In-Hospital Outcomes Among Left Ventricular Assist Device Recipients. Am J Cardiol 2022:S0002-9149(22)00722-6. [PMID: 35906126 DOI: 10.1016/j.amjcard.2022.06.053] [Reference Citation Analysis]
7 Jensen J, Omar M, Kistorp C, Gustafsson F, Køber L, Møller JE, Schou M. Sodium-glucose co-transporter-2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectives. Basic Clin Pharmacol Toxicol 2022;131:5-17. [PMID: 35510595 DOI: 10.1111/bcpt.13739] [Reference Citation Analysis]
8 Kalogeropoulos AP, Tam E. Intravenous iron in heart failure with reduced ejection fraction: just about right. Eur J Heart Fail 2022. [PMID: 35481845 DOI: 10.1002/ejhf.2520] [Reference Citation Analysis]
9 DeVore AD, Bosworth HB, Granger BB. Improving implementation of evidence-based therapies for heart failure. Clin Cardiol 2022;45 Suppl 1:S52-9. [PMID: 35789019 DOI: 10.1002/clc.23845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Kang C, Lamb YN. Vericiguat: A Review in Chronic Heart Failure with Reduced Ejection Fraction. Am J Cardiovasc Drugs 2022. [PMID: 35624347 DOI: 10.1007/s40256-022-00538-5] [Reference Citation Analysis]